Skip to main content
. 2020 Dec 17;11:596825. doi: 10.3389/fimmu.2020.596825

Table 1.

Clinicopathological characteristics of the study population.

Clinicopathological characteristics Total n (%)
Number of patients 60
Age at diagnosis in years (Mean ± SD) 46 ± 12
Histology AC 14 (23)
SCC 44 (73)
ASCC 2 (4)
HPV type a Type 16 28 (47)
Type 18 14 (23)
Other type 9 (15)
Negative 4 (7)
FIGO stage (2009) ≤IB1 43 (72)
>IB1 17 (28)
Tumor size b ≤40 mm 45 (75)
>40 mm 13 (22)
Infiltration depth c ≤15 mm 44 (73)
>15 mm 12 (20)
Vaginal involvement d No 47 (78)
Yes 12 (20)
Parametrium invasion e No 54 (90)
Yes 5 (8)
Lympho-vascular space invasion f No 22 (37)
Yes 24 (40)
Tumor-positive lymph nodes g No 38 (63)
Yes 18 (30)
Recurrence in 5 years No 52 (87)
Yes 8 (13)
Primary treatmenth Surgery 36 (60)
Surgery + adjuvant tr. 21 (35)
Chemoradiation 1 (2)
Neo-adjuvant tr. + surgery 1 (2)

FIGO, International Federation of Gynecology and Obstetrics; SCC, squamous cell carcinoma; AC, adenocarcinoma; ASCC, adenosquamous cell carcinoma.

a

Data missing for 5 cases.

b

Data missing for 2 cases.

c

Data missing for 4 cases.

d

Data missing for 1 case.

e

Data missing for 1 case.

f

Data missing for 14 cases.

g

Data missing for 4 cases.

h

Data missing for 1 case.

This tissue was obtained after conization in a patient with stage IA1 disease.